Elevance Health Reports First Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- US stock futures gain ahead of July inflation data
- Oil prices rise after ship attacks, US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Elevance (ELV) PT Raised to $605 at UBS
April 19, 2024 6:36 AM EDTUBS analyst AJ Rice raised the price target on Elevance (NYSE: ELV) to $605.00 (from $585.00) while maintaining a Buy rating.
The analyst comments "ELV provided a few more details around its recently announced CDR partnership, noting that the care delivery entity will start... More
Elevance (ELV) PT Raised to $600 at Wells Fargo
April 19, 2024 5:57 AM EDTWells Fargo analyst Stephen Baxter raised the price target on Elevance (NYSE: ELV) to $600.00 (from $557.00) while maintaining a Overweight rating.
The analyst comments "ELV's 1Q24 results were strong and earnings quality appears high. Story remains fairly clean from our perspective. Continued growth... More
Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
April 18, 2024 7:03 AM EDTShares of Elevance Health (NYSE: ELV) rose 3% after the health insurance provider topped earnings expectations for the fiscal Q1 and raised its outlook for the full fiscal 2024.
The companys first-quarter earnings per share (EPS) came in at $10.64, topping consensus estimates of $10.48. Revenue was... More
